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ABSTRACT
C
A method is described whereby a transevaporator is used for sampling
60-100 u1 of aqueous sample. Vol atiles are stripped from the sample
either by a stream of helium and collection on a porous polymer, Tenax,
or by 0.8 ml of .2-chloropropane and collected on glass beads, The
volatiles are thermally desorbed into a precolumn which is connected to
a capillary gas chromatographic column for analysts. The technique is
shown to be reproducible and suitable for determining chromatographic
profiles for a wide variety of sample types.
Using a transevaporator sampling technique, the volatile profiles
from 70 ul of serum were obtained by capillary column gas chromatography.
The complex chromatograms were interpreted . by a combination of manual and
computer techniques and a two peak ratio method devised for the
classification of normal and virus infected sera. Using the K-Nearest
Neighbor approach, 85.7% of the unknown samples were classified correctly.
Some preliminary results indicate the possible use of the method for the
assessment of virus susceptibility.
,z
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I. INTRODUCTION
Profile analysis has been the subject of considerable investigation,
with various degrees of success, in food quality evaluation, (1-12) in
air pollution. studies, (13,78) in the characterization of automobile
exhaust gases, (11) marine sediments, (14) engine oils, (15) and marine
oil spills. (16-18) The object of gas chromatographic profile analysis
is to correlate a. characteristic "finger print" pattern in a chromatogram
with the qualitative and quantitative properties of a sample.
In recent years, this approach has become increasingly important in
the biomedical field for the diagnosis of disease and the study of
metabolic disorders. (19-52)- A complete profile of all the constituents
of a biological fluid is at present impossible with available analytical
techniques'. The goal at which most workers aim is the development of a
complete profile of a selected group of substances (eg. organic acids,	 	 ^	 	 p	 (30,
31,36,44,45)	 (32')	 (22 39,46)	 (4C,41)
amino acids,	 steroids,	 carbohydrates,
)
etc.) or of compounds with similar properties (eg. vol a,til'es). (19-21,23,24,28,37,A
A comparison is then made between the profile obtained with "normal
samples" and "pathological samples" to establish any quantitative
s
differences that might be of value for diagnostic purposes. A knowledge
of the chemical constitution of abnormal peaks or peaks of abnormal
'concentration may suggest a possible biochemical reason for the disease
and lead to new methods of treatment.
Except in a few cases in which a ' strong clue exists to implicate the
role of causative agents,to a disease disorder most work still relies on
I	 -
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a serendipitious finding in a screening program involving the study of
many diseases. To maximize the chance of discovery as many substances
as possible are included in the profile. Capillary columns are generally
used for the analyses due to their superior resolving power.
Volatile metabolites excreted in urine have been extensively'
studied by Zlatkis et al (19 9 47 * 50)
	
	
(2137,5152)
 Liebich et al,
Matsumoto 
(48) 
and Novotny. (49) Abnormal excretion of C4 -05 alcohols,
octanols, cyclohexanone, 2-heptanone and pyrazines occur in cases of
metabolic disorders of diabetes mellitus.
Clinical laboratories depend to a great extent on blood as opposed
to urine for diagnostic purposes. Little data is available concerning
the occurrence and concentration of volatile substances in blood.
Technical problems such as the availability of sufficiently large samples
and the protein content of blood serum have rendered their qualitative
and quantitative determination more difficult. Dowty et a1 '(53) used
Tenax GC to analyze volatiles in plasma of patients vit 1h chronic renal
failure. Stoner et a1(25)
 
extracted volatile substances from 15 ml
.
 of
,,11(38
plasma with ether. Liebich and W 0	 analyzed 5 ' ml of serum by G"'-MS
and mass fragmentography using a headspace sampling technique. In all
these studies the sample size used for analysis ranged between 5 ml and
55 ml and the chromatograms produced contained relatively few volatile
components compared to urine.
The components of interest are generally present in low concentration
with the result that special techniques are necessary to overcome the
problems associated with the small sample size, low sample capacity of
3the capillary column and the need to introduce the sample as a con-
centrated plug. Two techniques that have been widely used for the
concentration of volatile substances from dilute aqueous solution are
solvent extraction (8'9,11,14-18'25,32,34,35'41) and headspace analysis
using a suitable adsorbent. (9,10,12,13,21,23,37,38,54 ' 55) The
techniques are complementary for samples that contain organics covering
a wide volatility range. A shortcoming of the extraction technique is
that some early peaks are masked by solvent whereas poor representation
of late peaks occurs with the headspace technique. The extraction may
be performed using a micro-technique but the headspace method generally
yields unsatisfactory results where only small volumes of sample are
available.
Zlatkis and coworkers introduced a direct micro-extraction method
for profile analysis using only 25-100 jil of serum. (*" -57) Zlatkis and
Kim have recently described an improved method of micro-extraction
using a transevaporator. (56) An aqueous sample is placed on a suitable
adsorbent packed in a small tube, the organics 
of 
interest are extracted
with a suitable solvent and transferred to a collection tube packed with
glass wool and excess solvent is evaporated. The volatiles are then
transferred to a capillary column via thermal desorption into a precolumn.
The extraction procedure takes less than 30 minutes and may be used with
as little as 25 jil of sample. The transevaporator extraction is about
three times more efficient than a direct extraction. Purified 2 -chloro-
propane was found to be a satisfactory extracting solvent and Porasil E
was found to be the best adsorbent out of '6 possible candidates.
.	 0
4The volatiles are present at trace levels in biological fluids which
consist principally of water so that the sampling technique has to serve
as a concentration device capable of reproducibly stripping a diverse
range of compounds from a water matrix. The original "transevaporator"
method has several shortcomings. A small excess of moisture sometimes
causes plugging of the analytical capillary column, and the chromatogram
was lacking in headspace component,.;. The recovery and reproducibility
of standard compounds were also lower than expected. It was necessary
-to modify and improve this "transevaporator" sampling system for its
general application to biological fluids. Good precision was required
and a more general profile containing "headspace" and "solvent
extraction" information from the same sample.	 1
When one is dealing with the metabolic disorders that lead to gross
metabolic changes, there is no need for computer aided evaluation.
However some clinical disorders may result in more subtle, yet perhaps
important, changes in the metabolic pattern. The very nature of this
approach leads to problems of an analytical nature. , For 'the case of the
i
analysis of volatiles, the current sampling techniques generate very
complex chromatograms which only reveal a full picture of their complexity
when high resolving capillary columns are used for the gas chromatographic
separation. The amount of information subsequently generated c.an no
longer be handled by empirical means and the use of pattern recognition
techniques and computer sorting are obligatory. (71) Although, the
selected sample can be characterized as "volatile" under that heading
is masked the chemical complexity of the mixture which covers the
5complete spectrum of polarity. The physical property shared by all
components is that they fit into a distinct boiling point range. The
successful use of such techniques as pattern recognition makes high
demands on the reproducibility of the profile; a feature which it is all
too easy to demonstrate is more often impaired by poor sampling techniques
than chromatographic error. (72)
Various pattern recognition techniques have been described to
correlate gas chromatographic profiles with the properties of a sample.
The purpose of pattern recognition is generally to categorize observed
experimental data as being characteristic of a particular sample type.
Moskowitz ( 3 ) used-multi linear regression analysis to yield an overall
dissimilarity of odor quality difference in flavor assessment.	 Jurs
(59-62)
et al	 used a linear learning machine pattern classifier to analyze
low resolution mass spectra.	 The linear learning machine performs as a
binary pattern classifier - yes or no, plus or minus, or class I or }
class II.	 A classification vector is computed by an interactive
training data set using known spectra that may overlap in'any or all
components.	 This technique has a disadvantage for the non-linear multi-
pattern data set compared to the K-Nearest Neighbor technique (KNN).
The K-NN classification method (63-67) is a multi-dimensional classifier
with no increase in complexity and is computationally and conceptionally
quite simple.	 An unknown pattern is classified according to the
majority vote of its K-Nearest Neighbor (K = 1,3,5 ... etc.) in n-space.
Computationally, all that is necessary is to calculate and scan a
distance matrix between an unknown point and points of a (mown group
established from the analysis of a training set. spy;.
4__	 _ 7
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Profile analysis of volatile compounds in body fluids could be a
significant  part of  large-scale preventive medicine program provided
that an accurate andlong-term reproducible analytical system coed be
developed. Specimen collection, storage and transportation should be
controlled carefully in order to eliminate any artifacts. The combination
of high resolution capillary column gas chromatography and computer aided
pattern classification systems, opens up new possibilities not only for
the study of gross alterations but also for the detection of more subtle
changes in profiles.
In an effort to establish the methodology for the early diagnosis
of viral diseases; a series of capillary column chromatogrpahic profiles
were obtained using a modified "transevaporator" sampling technique.
The complex chromatographic profiles were analyzed-by computer techniques
to develop a means of differentiation between normal and virus infected
sera using a two peak ratio method. -A training set was developed and
the K-Nearest Neighbor technique used to establish the predictability of
virus infected serum identification. Gas chromatography-ir.ass spectro-
metry was used to identify the , most prominent serum components important
to this study.
r.^
7II. EXPERIMENTAL
A. Adsorbents and Reagents
For trapping and concentrating the volatiles from biological fluids,
the adsorbent should provide adequate selectivity, thermal stability and
surface activity.
Porasil E (80-100 mesh) and glass beads (80-100 mesh) were obtained
from Analabs, North Haven, Connecticut. Porasil E is in the form of
perfectly spherical beads of porous silica with a specific surface area
of 25 m2/g. According to Cadogan and Sawyer, (73) upon heating from
200°C to 500°C silica loses all hydrogen-bonded water which provides the
active sites for adsorption. Since Porasil E was conditioned at 300°C
prior to use, water in serum was retained by Porasil E very effectively
after sample elution through this small column.
Tenax GC (60-80 mesh), a porous polymer of 2,6-diphenyl-p-phenylene
oxide, was obtained from Applied Science, State College, Pennsylvania.
Tenax GC has been characterized as having unusual and desirable
chromatographic properties. (74) It has been shown to fulfill the
requirements of efficient adsorption and thermal desorption for higher
molecular weight compounds. The temperature stability of Tenax GC is
relatively high (up to 4000 C), and it is widely used for headspace
sample analysis (19-21,37,38)
Glass wool (Pyrex brand) was obtained from Corning Glass Works,
Corning, New York.
8All of the above were washed with distilled ether and conditioned
at 280°C in a stream of dry helium for 12 hours.
2-chloropropane (Eastman-Kodak, Rochester, New York) and n•-pentane
(J. T.	 Baker, Phillipsburg, New Jersey) were distilled from phosphorous g
pentoxide (J. T. Baker, Phillipsburg, New Jersey).
	 Diethyl	 ether
anhydrous	 (Mallinckrodt, St.
	 Louis, Missouri) was distilled from lithium
aluminum .hydride (Alfa Products, Danvers, Massachusetts) and water was
distilled from potassium permanganate (Fisher Scientific, Pittsburgh,
Pennsylvania).
B.	 Serum Samples
A total of thirty-six serum samples from twelve male volunteers who
had been exposed to either "England" or "Rhinovirus" were supplied by
Dr. H. J.	 Schneider (NASA, Houston, Texas, U.S:,A.).	 These samples
form part of a study of immune response to respiratory virus infection
conducted by Dr. R. Couch, Dr. U.	 Knight and Dr. S. Criswell of the
Influenza Research Center (Houston, Texas). Serum samples ( .2.00-800 ul)
were stored in glass vials at -20°C prior to analysis. q
The serum samples fall	 into two categories.	 The first (Nos. 1 -} 6)
were obtained from volunteers who developed clinical symptoms of influenza
after virus infection.
	
The second group (Nos. 7 -> 12)- were obtained
from volunteers who did not develop clinical 	 symptoms after virus	 _
infection.
	 Each volunteer provided three serum samples corresponding to
a baseline sample taken prior to virus infection (Group I), a serum
sample ta.ken one day after exposure to the virus (Group II) and a final
zu
	.	 _
9sample taken 14-21 days after virus infection (Group III). Group (1)
represents normal serum samples, Group (II) virus infected serum samples
(irrespective of whether clinical symptoms developed after exposure) and
Group (III) virus infected serum samples from which all volunteers had
recovered clinically from the infection.
C. Transevaporator Sampling Method
1. Sampling Apparatus
The transevaporator used is shown in Figure 1 and is essentially of
the same.design described by Zla t kis and Kim. (58) Significant differences
are that the dimension of the Porasil E tube is changed to smaller size
(70 rim x 2 mm I.D.) and that a water condenser is included.
The micro elution column was a glass tube containing 0.3 ml of
Porasil E with a plug of glass wool at both ends. Prior to packing,
Porasil E was conditioned again at 300°C by purging with nitrogen at
20 ml/min for 3 min. The glass bead trap (3.4 ml of glass beads) and
Tenax trap (1.8 ml of Tenax GC) serve as a concentrating'column, in a
glass tube (110 mm x 10 mam O.D., 8 mm I.D.), tightly packed with glass
wool. The elution apparatus consists basically of a custom made
"transevaporator" and a conical tip centrifuge tube with a glass stopper
10/18) as shown in Figure I.-
2. Sampling Procedure
Figure 2 is a schematic diagram ot' a combined headspace and
extraction sampling procedure. The sampling procedure is performed in
Ri
FIGURE 1. MODIFIED TRANSEVAPORATOR SAMPLING
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two steps, the first being collection of low molecular weight volatiles
on a Tenax tube, the second being the solvent extraction of volatiles
coupled with collection on glass beads.
In the first step the sample (25 to 200 ul) is introduced to the
inner tube which contains 0.3 ml of Porasil E, a strongly hydrophilic
porous silica adsorbent. The upper tube contains 1.8 ml of Tenax, a
2,6-diphenyl-p-phenylene oxide porous polymer, which is an excellent
trapping material for headspace analysis. A condenser is included in
the apparatus to prevent excess water vapor from reaching the Tenax trap.
A stream of helium gas (16 ml/min) is passed through the apparatus for
5 to 10 minutes to transfer the volatile compounds from the porasil
tube to the Tenax tube which is then removed from the apparatus. Helium
(16 ml/Mn) is passed through the tube for about 3 minutes to remove
traces of water which would block the precolumn during desorption. There
is no apparent change in the resultant profile due to this procedure.
The Tenax tube is removed from the apparatus and placed in a desorber at
280°C for 10 minutes. A stream of helium (7 Ml/min,) desorbs the volatiles
into a precolumn, cooled in liquid nitrogen, which is then connected to
an analytical capillary column for chromatography.
In the second step the apparatus is converted to the form described 	 "a
by Zlatkis and Kim (58) by removing the condenser. The Tenax tube is
exchanged for a tube of identical dimensions containing glass beads.
0.8 ml of 2-chloropropane is introduced into the tube and is swept through
the porasil tube into the upper tube by applying gas pressure, Soluble
organics are extracted and transferred to the glass beads while most of
13
the water and high molecular weight material is retained by the Porasil
E. The Porasil E tube is removed, the apparatus is reassembled and the
outer tube is placed in an air bath maintained at 50% to heat incoming
helium which is passed through the apparatus at a rate of 16 ml/min for
10 minutes to remove excess 2-chloropropane and traces of water. As in
the case with the Tenax tube there is no apparent change in the resultant
profile due to this procedure. The organics are transferred from the glass
bead trap to the capillary column by the same technique as is used for
the Tenax tube.
i
3.	 Transference .of Sample from Trapping Tube to Analytical Column
The trapping tube was placed in a desorption chamber maintained at J
280°C, connected to a stainless steel precolumn (30 cm x 1 mm I.D., coated
with SF-96) and cooled in liquid nitrogen.	 The volatiles were transferred
to the precolumn by passing helium through the system at 7 ml/min for 10
minutes.	 The precolumnwas then connected to the analytical capillary
J
column, the first 30 cm of which was cooled in liquid nitrogen.	 The
sample was transferred from the precolumn to the analytical column by
heating the former to 180°C with an air heating gun for I minute while
passing helium through the system at a rate of 1.5 ml/min.
D.	 Capillary Column Gas Chromatography
1.,	 Analytical	 Capillary Column
In this study, all analyses were carried out on stainless steel
capillary columns (100 m x 0.25 mm, I.D.) which were purchased from
' A
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Handy and Harman Tube Co., Morristown, Pennsylvania. Newly acquired
columns were first checked for leaks and then modified at both ends by
slipping short pieces of stainless steel tubing (40 mm x 1.0 mm I.D. and
1.6 mm O.D.) over the end, after silver soldering, the sleeve was fitted
with 1/16 in.	 ferrule and nut.
Cleaning of the new columns was done by washing with several 25 ml
portions of acetone, n-pentane ,	 chloroform, alcohol, water and acetone
at 500 psi.	 After drying the column at 150'C for one hour, the quality
of the empty column was tested by injecting a series of test substances
r
i
` (cyclohexane, benzene, diethyl 	 ketone and ethanol) individually at 80°C.
All test substances should be free of significant tailing. 	 To improve the
quality of empty columns which show severe tailing, the column was filled
with etching solution (5 g ferric chloride, 15 ml cone. HC1 and 60 ml
distilled water) for 2 hrs and washed-with distilled water _several times,
. J
followed by solvent washing.
a
The liquid phase used in this study was 5% Witconol LA-23 (Witco,
Houston, Texas), an alkyl aryl 	 polyether alcohol, in CH 'C1 2 solution
(W/W).	 A post column of identical	 I.D. is attached at one end of the
analytical_ column and the other end is immersed in a beaker filled with {
water.	 The flow rate throughout the coating process was controlled at
one bubble per second. 	 After drying overnight at room temperature by y
passing nitrogen carrier gas the coated column was conditioned in the
gas chromatograph at a low flow rate and temperature programmed at a
rate of 0.5°C/min from 40% to 160'C.
aa
tl
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The efficiency of a coated column was checked with a decalin mixture
(decalin:diamyl ether = 1:1, V/V) at 120°C, isothermally. The resolving
power was also tested with an aromatic mixture (cyclohexane, benzene,
ethylbenzene, meta- and para-xylene) at 80°C, isothermally. Most of the
columns which were coated with this method gave 250,000 theoretical plates
and provided base line separation between meta and para-xylene.
2, Gas Chromatographic ,onditions
A Hewlett-Packard 5830 A gas chromatograph (Hewlett-Packard,
Avondale, Pennsylvania) equipped with flame ioni-zation detectors and
connected to a Hewlett-Packard-18850 gas chromatography terminal was
used. The serum volatiles were separated on a stainless steel (100 m
x 0.25 mm I.D.) capillary column coated with Witconol LA-23. With a
helium carrier gas flow rate of 1.5 m1 min 1 , the column was held iso-
thermally at 50% for ten minutes and then programmed at 1.5% min-1
to 160°C and maintained at this temperature for eighty minutes. 	 3
3. Gas Chromatography-Hass Spectrometry (GC-MS)
Gas chromatography-mass spectrometry (GC-MS) was performed on an
LKB 9000 instrument (LKB-Prodkter AB, S-161 25 Bromma 1, Sweden) with
a single jet separator and a Perkin-Elmer 900 gas chromatograph. The
ionization voltage was 70-eV and the scan time for a mass range of 20 to
300 atomic mass units was 4 seconds. The temperature of the separator
and ionic source were set 220% and 250°C respectively. Analytical
procedures and chromatographic conditions were the same as described in
the previous section. When possible identification was confirmed by
16
comparison with standard compounds available in the laboratory, otherwise
manual interpretation and comparison to library spectra (75,76)
 was used.
E. Data Handl ing and Computer Interpretation
The operations which constitute the interpretative procedure are
summarized in Figure 3. Visual inspection was used to identify those
peaks common to all chromatograms. The peaks were normalized and this
formed the data,set for calculation of system variations and variation 	 k
between individuals within each group. A second data set selected on 	 x
the basis of the magnitude of their difference between groups was used
to calculate al'l possible peak-ratio-combinations and diagnostic ratios
selected. These ratios were autoscaled and used as input for K-nearest
neighbor classification
1. Auto	 32,67)
E
In autoscaling, each dimension was adjusted to a mean of zero with
unit standard deviation. Hence:'
X.- 
Xim - x 
	
##
im	 am	 i
where Xm is the mean and 
am 
is the standard deviation of the value Xim
for the ith feature. Xim is the new autoscaled value. This preprocessing
minimizes the effect of differing data magnitude. It was known that
autoscaled data gives high rates of correct classification in'K-NN method':
2.' K-Nearest-Neighbor (KNN) Classification
(32,63-67) 	 A
;a
j
This pattern classification technique is based upon the assumption
t^
o
FIGURE 3. SCHEMATIC DIAGRAM OF DATA PROCESSING OF
CHROMATOGRAPHIC INFORMATION
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that "the closer together" patterns are, the more closely related are_tne
sets of data. Closeness was defined as the distance between an unknown
data point and points of a known group (training set). The distance
between point 1 and m is defined in this case as a Euclidian distance:
dim	 1k	 1 (X l k - 
Xmk) 2 X1/2
where k is the number of dimensions in factor space. In the case of the
single (k = 1) nearest neighbor (1-NN), the unknown point is classified
as the group which gives the smallest distance from the points used for
the training set.
3. Computer Programs for Profile Analysis
All programs were written in Fortran IV and run on the University
of Houston computing center's Honeywell_ 66/60. These computer programs
consisted of a short main program which inputs a set of data, initializes
a number of parameters, and calls the several subroutine 'subprograms;
a
percent normalization, calculation of relative standard deviation,
writing, calculation of all possible combinations of two peak _ratios,
autoscaling, sorting in ascending order and classification by K-nearest
neighbor methods.
The array A contains the raw integrated peak area. It is dimensioned
for up to 36 chromatograms (N) of up to 37 selected peak areas (M) per
chromatogram. The following is an example of an actual computer program
used in thi s study.` 77
^1
1 . t:21	 19
C
C )F f`*i. : +'rrc:1'ir ;1" , ^ ir'.` i. a irk * 4w• !	 irn	 l 	 +.^ *^.t'^v4'kt: k* :> ► kiriric
(; ^;x^; :•:ti^ :i•^•:^#^oS• * ^•'tx*h•4.•^*'#.•Etta•* 'k i•X^t^it^ #• itty :4^i^;•titittk*+Yk**
C	 F'f?t)F T L E 4P! L.YS,IS OF VIRUS 7?k^ F ECIED Sr-PUM
C	 DATA, Ig 0RMALT7c:D D47A	 AK RAT10	 C4LCLiL T10jN' OF
MEAN SD. • PT. CErEF. VAR	 .4MD AU T0SCALING
(; w*rtt. :r'i^'l • i^+a7t^' kir:t'kxi• :'•. kkxxrt ••k*x• rr:Yr'k^rkk *±K at^C * ^***^iirk •^kir#' * ^*die
C ikttreYit*X**ttikrtHrK*r.xi:rlfr+C'}:cy4*Iri^crfr*,4*kYc**^rkei##ttk**!c*^^i*trtt^r
C	 s
C	 AUG. 10, 1975
	
K,_Y,;.1-F
Cr
uC PROFILE ANALY313 OF BIOLOGICAL FLUTO
C N	 NM,iE'ER t.ir U.ILUM N3 (S,`M c LE NUaa' E"R81
C m	 NUMSFk OF k0viS (SELECTED PEAK,,; OR PEAK RA TI O)
C A
	
DATA POINTS ARPAYO A(M,N)
C S	 PERCFMI N'UMALI'ZLED DATA POINTS; S;^i,^J}
C P = P=" Ar; RATiO; R0`10)
ASLH	 AUTOSCALED POINTS ; A8LSPA,N)
G
	
	 q
^^OIfF?L'c PRECIS IOtJ 3r at.F^,MCj'•NEi,S^f3,PTf:V,f?
OIhENSION A(37,"16) 4a(: 7,36),kSLi3(37,36),riFA^lb:a7;,
I	 50f3C37),P TCV( 7-7) gR(7,36)
C
:iE:AD(5, 100	 N1Mf
INITI A LIZE- DATA POINTS
GO 1^ T— 1o M
DO 10 J -- 1, N
ACI,J)-0.iy
5 1 j )= 0 0	 pAGr IS
9(I , J ^ o o	 ORIGINAL
A S L H! C I, J) = 0 0	 OF P44R QUALI'T'Y
MEANS(l)=,',l,0
SDBfI)^o,o_
n T.nyf1)^^^ia
10 CCN^T INU '
C
-• SRI T^ (61i8)
WRITE (6 t
—
i0 )
DO 15 I	 1 ,M
PEwD' (9. 1 101) ( A (IoJ)t J= IAN)
Ptt^ITC (t>,F^1} I, (A4I,K}, K^S,Ny
15 CONTINUE
4
C N0RMAL!Z4TlON(PERCENT) 0F DATA
CL. NO RM CA,N,N 'd)
CALL WRITE ( itJIM)
C CALCU ►.ATION OF kEFRODUCIBILITY
NRI_TE C693S0}
L=1
NN	 12
20
16,421
KL	
3
C!tLL	 CALC	 ( i3, L,N,rJN,KL 9 t^,f EANi3 9 SCE3,F°TCV	 )
ViRITE"	 (51310)
L
CALL.	 CALL	 (F1,L;N, ;N,KL,rI, r^E,^iv	 ,SCEti,f^TCti
v RITF	 (69350) 4
L = 3
C4L ± 	 CALC	 t!3,i..N,r:!J,K ► ,t ,ME:Ar!E3,SuEi,Pi4^' 	I,
100 FORMAT(2110)
101 FURrAAT	 (	 3(YF8	 0,/).9F8.0	 )
i .
1 13 F	 ".1	 1	 •	 /	 ^^ *	 *	 ;; * *	 k	 I	 T	 * * * * *	 ^ 1Y `4 p is lt: )C^^k .AT
	 r^.	 /	 *	 *	 ^	 U.aTr	 U. ti	 S..	 ( IL H-1 	 ^	 9	 . . ..
1xir9rfcr^ir**its)ki:#: k^a^^c^^•ri•%,kk•^*^^^r^^k:i^Xx•z3,^A'k4*^;*°,,%!1
119 FURWA'f	 (//,	 "PEAK",2X,ail-1"	 ax	
Il l _ 2 11	 p;^tin^..zrr,Ux,
rs ^	 :r	 n	 "	 "	 "	 r	 " 31	 e^1	 , ua • 	 c „ 2	 .4X,	 2-3	 v,ate,	 N 1 	 ^c..,	 ,..	 s
4 X	 toy„3”	 4X 1 nU„i:i	 4X 9 11 [1 	 2” t4X	 ii1M yz 	 :+x
11
	 ,•	 n	 "	 "	 "	 "1	 S	 1	 ,riy f	 5..^	 ,u,.u 	`? «3	 , t1^,	 o — !	 ,4X,	 o^^ • 	 -
ng o 	 r	 •	 •	 1	 ,	 ,	 ,	 -	 ,
1'	 x•n3„"^4X,s:t3..:^t's^:i(.:ry„l:t^^^,
" 1	 nq."^".,uX,"9„3",^1X,"lU «1",3Xy "102"USX, i
1	 " 11"1" 13^aIll 1 - 2",3X,"11 „ 3 ",3X,"12-1',-3X,
1'	 12-2",3X, "12„311	 ///
	 )
121 FORMIAT	 (I3,	 18'r 7.0./ 9 3X,	 18F7.0,	 //	 3
330 INFECTION	 12
3 110 F'UHNAT(1Mla//q' I **4FTEa	 INFECTION	 12	 SawPL=S+:^",//)
350 Fo RM11AT(Pi 1,/!," **AFTER	 CURE	 ,	 12 SA-+RLE5**I1,//)
S7`Op
END
,r
ORIGINAL PAGE IS
POOR QTJALITYOF
{
1
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o,
^z
21
•
-
• 	 r
C ,ki^a	 r+	 *,t ^, 	 :^^h^^,;	 <,F	 :L,+rXx	 is	 x'c	 *^*'A- k*
♦
i^
J
' ^ k n f( /^ `n' ^ ^^ ^ :•(X %^ ^ ^ ^ ,`' :` K * 'K ^. ^( '1' ^ It' i+. '^ ^' .4 '^' 'R(' :' ^' •^( •/• lY '^. ^: * I4 }f .1 3 1(^ ^f 'k f' { 7t ^f 'l: X 7^f ^' •^
c PnC)>rcD	 VIPUS	 AMP( - C q	 REPRODUCISII.1 TY
C N 10RH l.1Z A T ION	 S^MPLr_S
C PEAK	 RATIO,	 AN I^ 	 MEAN	 SD,	 PT,	 COEF.	 VAR.
;,:•kip,tri:ici•,^^;itir•ktkt*x^,a+ir:4:^•^ry^tk^^kstt.#*i(***^c,kst,F^t*st^'x^***^c'k*
(
C ^( ^f }^i ^ ^ ^t 7F 7^C ^t l^C •if if 7^(^ ^l * lY *^ A' ':^ ^• :Jf K X^ 1't )C if 1f :^ ^C ^l ^: 7f 1^' ^( ^j '^ f 7t ^( 'k ^c ^ '(f YF "^ '^* 1Y ^ ^' i^t It ^f 'X ^
C• AUG.	 10,	 1975	 K•Y.l.£E_
-C PRO;'ILE' ANAL YSI S OF	 53I0LOGICAL	 FLUID
G
C N	 ^!,""5ER	 Or	 CrLUr'NS	 (,SAMPLE	 NUMgFRS
C NUMaER OF	 RD;vS	 (S E LECTED	 PEAKS) -
C A	 ..	 D4-TA	 POINTS	 ARRA)';	 Alm,N) #
C S	 FERCLENT	 NC1Rt'ALI
	
El)	 WJA	 POINTS i 	 B(h'^N)
C .ASLJ	 AUTOSCALED	 POINTS	 ;	 ASLl3 (MIN)_
C R = PEAK	 RAT IO
DOUBLE	 rRECISiO ;'-' 	 h,bSLF,MEANSISD8,PICV,R
01MENSlI1tJ<	 A(57 9 %).8 (37/,7),A.:L8(37,7),P K:4NF(347)^
1	 SU8(S7),PT'CV(37),R(2y7)
RtAf)(s,1J^)	 N,i4
C IN T T? ALI Z'E	 DATA	 PUI:NTS
00	 i 0	 I	 1, M
CU	 10	 J	 1,	 N II
A(IJ)=n,0 1
°CI,J^=Q•0
R(I,J)	 --	
0,0
ASLB (i ,.T) =0.0
►^: A N dtI) =Q.G 9
PTCv(I)=o.0
10 CONTINUE
V;RIT€	 C641rQ)
DO	 2 0	 I	 t'1
RIT -
	
t6	 121)
	
I4(A(I,Y)jK= 1,N)_
20 CONT INUE
G'
C !^ORMAL l ZA7I0 t4 f PERCE'N T)
	
OF	 DATA
CAUL, NOg M	 (	 A,N,M fB	 )
C CALCULA TION OF MEANq	 S,D. 9	PERCENT COEFF•	 VAR,
L
NN
KL=
CALL
	 CALL	 (P.	 L,t^,^dti,KL,M,rtiEanu,SDf^,aTCV
C C ALCULATION OF FFAK RATI O OF POOLED SwRUy
^t
WRITE	 ( 6 ,1r2)
22
16.42.5
DO	 21 3 	1	 =	 1, 2DO25J=1,N
IF	 (	 J	 . Ef).	 b)	 GO	 TO	 25
I F 	 I	 .Eft,	 1	 )	 GO	 TO	 2 8
IF	 (	 I. EQ.	 2)	 GO	 TO	 2 9
26 =:(I„ J)=H(16,J)	 /	 6(25,J)
G0 TO 25
29 R (I,J)	 =	 B(29,J)	 !	 6(34,J)
25 CONTiNU IE
ORI E:	 (6,lc'_3)	 I t 	CR(I,L),	 L=104)
23 CONTINUE
C	 CALCUL,,TIGN OF MEAN,	 S.n,,,	 PEPCENT COEFr.	 VAR.	 OF	 RATIO
M=2
CALL	 CQLCT (R,L, ^^,r^r^,KL,^!,MEAr^B,SOS,PTCv	 }	 r
YC	 AUIOSC.ALING OF	 PEAK RATIO
CALL
	
AU T s
	
(^, rs 	>^	 ^.,^^.	 ,,	 ,ANF^ ,SDB,ASL^
	 )
C	 CALCULATION	 OF	 MEAN I SD,	 PT„COE:F.`JAR.	 OF'	 AU OSCaLED	 POINT
CALL
	
CALCI
	
(aSLK,(,,^^,r^N ,KL,^^,^EAr,N;SU^s,°TCv) 	 a
100 FORMAT(2I10)
101 FCJi MAT	 (	 7F10.0	 )
120 FORMA	 1 I ,6X, "xx kl)aTA	 PO!f,iTS***'; „/, I I x,"PEAK	 140",
1	 5X,"SAMP	 1",8x, ll sA f•1P	 :11,	 8X,''SA M P	 3:"'8x,
I	 "SAMP	 4",8X, "SA rrP	 5' • s8X	 it 'sAIMP	 6!1 	8 , "SAMP	 711
1	 //	 )
121 F0Rl,AT	 (/, 1QX, I5,7F14 ► .0)
_122 F0Pkl AT'(1)-1,///,bX, r '**PEAK	 PA'T10	 OF	 i/ a ,	 5:7
1	 ***	 * 	 ", / / , 11 x, "PEAK	 NO",
1	 "SAMIP
	
11 11 ,RX,"SAMP	 5",8x,°S0',P	 1 11 ,6h,"SA1l p 	711,
1	 5X,11-SAMiP 	 1 11 1 8X,"SAMP	 2" 9 8X 9 11 SAMP	 3 "98v1
	
.
123 F'ORNAT	 (	 10X 1 15 1	7FI4,2,
	 ^/
16. .31
23
C
C **:t*** A **** * ** .A7;• 7:' \ 1: `l• .  }C * 7k ?: * 	 1y' 7} * _{ A...
	 + '1. '^ * * * '• (* ^i * X f * 7C :1f i^ ^f i^
	
* *' * 7:(
 k: k ** k4k*it>i' fi *it'k ic
C PROFILE	 ANALYSE)	 '.)F	 HE'FORr ,AF TER	 ANN)	 CUR E 	 VIRUS	 SAti?PLE
C '-R ELECTE0	 %	 PEAKS('NORMALTZED)
	
PIt)::19
	 P19=21
C P2o= 3, 	 P2-3=4,	 P29	 S.	 P31 :-.6	 P*-14=7,
C RESPECTIVELY	 ANN	 CALCULATION OF PEAK EZv TO
C RE:PNGDUCIFILI T Y	 OF	 P '6- ,%K	 RLTIG	 N ITHIN	 (;POP
C ic^rtr # Jc •'n^ haaCAritk^ * ilk^tt^ti: t ^'r'iC^Str	 1rFr^itXtYisitiitlt /(* 74tit^Cfst*iltkk u
^y^;^: ic•::>te', t^'*r.kk^r * ^•*ai4 * ^•sY^*s^fc•^•^^r'^sr^;Pik+t^ • ^l•**^'fi * tkrYIrit^tVt7ic:: t.K^cit S
r
C AUG4.
	
10,	 1978	 K.Y.LEE
c
C PROFILE	 ANALYSIS OF	 F510LOGICAL
	
FLUID
C N	 NUS BIER	 OF	 COLUr,"'IS
	(SA ?AP LE	 NLi^f;r.RS)
C M	 =	 NU I.•, ER	 OF	 K rjwS
	
PEAKS}
C 6	 = PERCENT N0RM4LTiEf.' 	 DATA	 POINTS:	 B	 N) -.
C ASL5	 =	 AUTOSCALED	 POINTS	 LSL6(?n,N)
C R	 =	 B EAD	 RA11c)	 4,	 f2(M,N)
4r
I
JDUFLE
	
P R ECISION	 13,ASL. 8*RjEAN6,SD8,PTCV
DIMENSION
	 $-(?, gib) •4$i.F("l,iE,),R(7,^6) •
I	 ^.rAr^ac^a,scc^a,^TCVC7a
;,,
READ(5, 100)	 N,M
C: 1141 T 1 6 L1 ZE	 Darr,	 POINTS
DO	 1 0	 I	 =	 i , n;
DO	 N
R(IsJ)-0.0	
..
^
MEAN1	 i(I)=0	 0 1
PTCV(I)=O,G
1C'
	
;;C^! T 1fvUF
C
WRITE	 (6,120)
Do	 i's	 I	 :	 1
REAb	 (5,10+)
	 (3( t,J),	 J=•1,N)
VIRIiE	 (6 1 121:	 I1	 Co (T,K )j 	 K=1,N)	 -
15 C ON TINUE
c,
VNRITE
	
(6,220)
CALL
	 16RITE	 :S,`^,wt)
C CALC(J't.ATlOw	 OF	 PEAK	 RA71OCNIOR-MAL'IZEI))
CALL
100 ,.w0RtA4T{21 10)
101
	
FORMAT	 (	 3'l0F8,2,/),	 6FA.2	 )
120 FOR MAT	 (JHl,//oAXq"**SELECTF- D	 7	 PEAKS,	 NOFMALIZEO
Z	 ><.^FYtft7Y^' ir7l"ktilrx^';!r•kt*tdrk, i; w krr 'k*:k fr ^: ^i>1'tk#*'ktNtYtkalr^ *1:7kIt+^^/,
"?OAK'caX.,,,1-1", g X^n1M^ ",,4X , nl^^u ♦4X,#
24
16,431
1 ".2u1
	
112-311, 4X, "3- 1 ",4X,.113-211	 +
G
^. u'. X , "3-3" , 4 X 11 (^ wI
V
 % LJ X , 11 14-2 11 -1 4 X , of (^ .^ 5. is w,( ,
1 1; x., 11, 	^:X, "5»fi n ^ ,:X, 17 5-3 n ,GX, "E:-1", a X, 1'6-2",
X
	 II 7 	!!	 it '/	 '1 !1 ,	11	 w	 11, //,,	 ^-1	 ,4X,	 ^	 4X,	 7	 3	 ,4^o "b w 1 n ,4	 6X
y
8 - 2 ,+ ,11X,`-- 3 11	 1u X, "9'" 1 ",11x
1 +t	 9w3,1,	 >:,1l10,,111,3X,1110-2",3X,
i 10-3
1 11-1",3X,1111-2",3 X, "11-3",3X,,"12-1",3 Y,1
„12-2"-)3X,1112-3",	 ///	 )
121 F OR M AT (i3,	 i8F7.29/, <Y,	 15F' 7.2_,
220 r'GP,,ltT ih1,//."****-AN(J RMA L1ZE D DATA,	 7	 SAMPLES ,^*x*
._	 1;t^^t^t ** ^Ic^t1c >; Ic**rt7Ftk^^C,k*ic*^k * ir*^Ot*^c ** 7k Mc^CYr^` it>t*^1rr*t►: ^rl',///) r
STOP
E?gyp
v
ip
1E,,J29	 25
C
Cyr.,: xz,*,r:t:xk**t:x,t*xtrk ► *^*t^t*+*t<*utc**,^*,t
C l;>:^ir^.° k^r*w*,t^tr^^cktrt * ic*rtkttirkr^^rtr +; ^e^cstF * ^C*i*t^yrltrk /* ^s^riir
C PROF ILE
	
ANALYSIS
C AU ASCALING OF SELECTED 2 PEAK	 RATIO,	 • 1/4	 AND 5/7
C';X7k )t77tK' ieir kxii * fir	 tir^rk7	 f it^ yckk * tc	 r^F^ftir^ckrrt'r^r	 t * rtiYirir rir'	 1^c^71lctc
G ttcx*xitrtrx kYtItk^hfrYC * ^Cir^C * ^ arc **** riY+ktk * yc#i+^'*tcic * irxk ** ^ trkYtkY;
C
C AUG.	 10,	 1978	 K.Y.LEE s
C
_C
C PROFILE	 ANtLYSIS OF
	
BIOLOGICAL	 FLUID
•	 C
C N =	 NUMBER OF
	 COL'Ul"NS
	 (SAMI PLr	 Niihi g r RS)
-C M = NUN8ER OF RO q S	 (SELECTED PEAKS OR PEAK MRATIC)
C R	 =	 PEAK	 PATIO	 DATA;	 R(MIN)
C ASL IB	 ;	 AUTO,SCALED	 POINTS
	
;	 ASLf (MjN)
DCL:?Lr	 PPECISI0N	 RI ASL?,ME"'NF,S11r9,PT0V
DIMENSION	 R(2,36),ASL5(2,36)gMEANi3(2),SOE;(2),PTCV(2) a
- 
C
READC51100)	 NM
C INITIALIZE DATA POINT
- nO	 10	 I_ =	 1 ,n
00	 10	 J	 =	 1 r 	 f•i
R(I,J)-0.0
ASL6(I.J)=0.0
MEAN6(I)=0,0
SD8(I)=U.O
PTCV(I)=0.d	 - s
10	 CONTINUE
e
NiR'ITE
	 (6,120)
y
DO	 15_I	 =	 1 ,M,
kEAO	 (5 9 101)	 (R(I,J),	 J=19N)
WRITE
	 ( 09121)
	 L,	 (R(I,K),	 K=1IN)
15 CONTINUE
C
C WRITE	 PEAK	 RATIO 01F	 EACH GROUP
_I
WRITE	 (6,151)
CALL.	 WPITF	 (PINIM)
C CALCULATION OF	 MEAN,	 S.D,,	 PE-RC£NT COEF- F	 VA ►R,
L =	 1
NN	 36
KL	 1
CALL,	 CnLC	 (R,L,'l,wN,KL.,N+,M	 AN g.SD8oPTCV	 3
C AU'tOSCALING	 OF	 PE A T	 RATI01	 M E.ANN0. 0, 	 S.D.U1.0
CALL	 AUTS	 (H,N,.,Ao AlF.QNb,SOci,A3L,9
	
)
WRITE
	
(6,126
CALL WRITE
	
(A!iL3,h4M	 1
''
C
100	 FORMA T (2I10) ^,
2 
16,42 7
101 FOP-MAT C	 3(SGF3.2,/),	 6F8.7	 )
120 FOR	 A T C I H 1 , //, AX, " - :t	 SELFCTE. ^	 2	 PEAT:	 Rt.7I0*^:",
1 '11 /4 	 AND	 5/7,
1 "PK	 RTO"	 , 0 l°1",Uh."1-2",^t^,„j~3u,4X,
1 a? - l ny uv^n2- 2u^AiX^n2-31s^!!X,"3—t°,UX, 13-211
1 ;i, 11 3..3 11 i (^ X + /:^, 	 it	 (!^	 11 U ^+211	 UX	 It4	 3 11	 U hS	 t	 t	 t
1 n	 n	 u— 2 11	 n	 1t	 (	 :, i	 . n	 n	 1r5^1	 ,4X,	 5	 ^.	 .ux,	 5~3	 ,uX,	 ^-,	 ,u;,,	 /,~2	 ^	 u1 4X9,c6- 3;1, 4X,// v6x 	 7at	 U^5117-211`4Xv117~3'',
1 ax	 n S„ 1",4Y.	 94X.. 4 "F-311,4X,"9..i11y:;;(,
1 "9- 211+ 4X ,11 4- 311,^l x , 11 10"1 11 . 3X , tt 1^/-2"	 3 X ^
10 -	
3x s
1 ,39,"11-2"73X."11-3"13X,112-1",3Xt
1 It 1 2-2",3X,"12„3n-^
121' FCIRMAT (I3,
	
18F7.2,/ 1 3X,	 16F7 .2, 	 /////!)
126 FOR A A T C' 1' ,SX, ”*`*QU T 0:3C= LING	 L)^	 F'EAK	 RNTIC y` k****	 r
1	 ^`*?:'New#l••k^C^tirk*•kttr*tk^l•s^ti: * ^tr•k +t.^c>^^k+t?t ** ^;'>t'*^c ** ^icfr^M,//I
	 x;
151 FORMAT (I t-!1,	 SELFCTED	 2	 PEAK	 RATIO?	 k***^^>r>^x
1 kYit^ttit ** ic*^t * ^Ir •is^l arc+k:ltRi 'x*****xx*x;cYr'kt**,t *#+t +c*^trir *"
 , // ^
BTGP
EN DU	 r	 j
17.139
27
k*ti^r,tir},tdtk*+M 7!* pct	 l*A4**aric^tzlit#ts:kicRkrcir*iic ► 3^c***fit*'r****
C 7t**Fk+:+*k*^,Ii kxktk#k^**k;ck^rtctyK*kktrcYw*irytki,k*tk*x*AxytF^
C K-tv ,	 PATTERN	 RECOGYY 4IT1()-•t
C NORM AL OR	 VIRUS	 INFECTED	 SERUM
C **icr * 'r±t*: * ^1+tk rl Ott *
 kicYc±	 riYk * ^ekk*^r{'	 t^ tt # ilr* k^tk^^r ***:rkicr.9e
(: ^^*i;**icxir*yc^c***it7^r^kict#**:^t1k^c***^r^c+k^i#*1c**k**+tr^1c*it***ict*tic
C
C AUG.	 10 9 	 1978	 K.Y.LFE
C
C PROFILE	 ANALYSIS	 OF	 BIOLOGICAL
	 FLUID _,K-NN CLASSIFICATIDN •
C
C M	 =	 NO.	 OF	 UNKNOWN	 SAMPLE;S (ROvi) :
	 M(I) 
C L	 =	 NO,	 OF	 TRAINING
	 SET(kO'rt)	 ;	 L(J)
C ' ,N	 NO,	 OF	 F A CTOR	 SPACE	 (COLUMN)	 S . rJ(K),
	
K=
C X':	 UNKNOWN	 SAMPLE	 SET;	 X(I,K)
C Y	 =	 KNC)v,N	 TR4Ii•i7N,;	 SET	 ;	 Y;J,K)
4 D	 =	 EUCLIDEAN	 DISTANCE	 IN	 N(K)	 SPACE.	 BETiNEEN	 POIN TI,J
C
DOU6LE
	
PRECISION X,Y,D
DIMENSIO N
	X(26 , 2)	 YC1G,2)9
	 0(26910) , JJ(10)
C
READ
	 (5,100)
	 L,M,N
C INITIALIZE DATA	 PCINT3
Do	 10	 I	 =	 1,M
DO	 11	 J	 =	 l,L
00	 12	 K	 =	 1qN
X(IqK)=O.c
Y(J,K)=o.o
D(I,J)=0.0
12 CONTINUE
11
	
CONI• T NUE
. 10	 CO N TINUE_
C
ctii<iTL
	 (6.1:0) -^
DO	 i5
	 I=	 i,N
READ
	 (5,105)
	 (X.(I,K)_,	 K=1 ,N)
rRITE
	 (6,112)
	 I.	 (X(ItK),
	
K=1, N)
15	 C0 NI T INUE
AR11E	 (691-I3)
D O 	 17	 J	 -	 11L
READ	 (5,106)	 (Y(J 9 K) 9
	K =11N)
aiRITE_ (6,112)
	
J 9	 ( Y (J, K ).	 K=1tN) h
17	 CONTIN;JE
C
C CALCULATION OF EUCLIDEAN DISTANCE
	
IN_
	
2 FACTOR SPACE
sY RITE	 (6,220)
0.0	 20	 1	 =	 19 M
GO 30	 J	 =	 11L
JJ (J) =J
0(I,J)= S (aRT ((X ( I.1)-Y(J91))**2+	 (X(192) • YCJ,2)')**2)
30 CONTINUE
a
22
17.13
^tiRITE (6^ 11
	 I, (D(I IK) I K=1 ,L )
20 CU N T INUE
DO 31 I =1,M
+`rhITE (6,221) I
DO 32 J=1 ,L
32 VIRTTE (6.222) JJ(J), D(I,J^
1 CONTINUE
C SORTING AND CI.ASSIF'IC TION AY—i<—NN METHOD
CIA LL SORT
100 FORMAT (3I12 )
105 FOt<MAT C "F10.2 )
100, FORM AT ( 2F 6.2 )
110 k'OR ,A-A7 (.f'•1,	 SAMPLE SET ***x*^ sk^x ***
1 kki:turd,•kr:#^;•.fit;kit•k^:**z:k^^i:^*•,k•k^r±kt'skY:Yx^lick*icickk"^fl^
	1 	 "SAMPLE N(J",SX,"X(I,1)ss,,llX,llX(192)ss9//)
112 FOR M AT ( 110, 2F10.2-,// )-
113 FOiRi AT (1H1,^/,';*^kthaa;^I';C SET FOR'K--,'4(j**sx ^^:t k
	
.. 1.
	
BEFORE AND AFTER INFECTION ***^**^* rx***X*^*"^//,
r	 '
	1 	 "TGAtr!Ir•,G ST11 vuXv "Y(J,1)",u%:^"Y(J,2)".//^
11 u FCRMtT (I7, F• 9.3,7X.5F9.3, //)
220 F(')P^4AT C1HIa//, "*** K - INN CLASSIFICATIO,! ** *:Y***X*",
1 /,"******EUCLIDEAN DTSTAtiCE 1)(1,J) I n. 2 FACTOR **
1 ******xt*t**xf**x*K****^-**************",//,17X.
1 '+**1FAI.NjW^,' SET	 **",20X, "TPA ItvINU SET(ItiFECT)
1 *^ss^/,s^SAt".N	 77X,"u 1 1117X4"P11"96Xq1187" g4X,"h10".
- 1 (^:`,,"C31c?"^15^;,"AI'"w%X^"A2"y7X^",13"sbX9stA7"^fi!(^^rA^^a^
221 FORMAT (///,'l***3AMP=$1,13," *****^',
222 FORMAT (10X 9
 10(14 9 F8.3
STOP
E.ID
t.
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16.422
	
Un R.nUTI,NE PROGRAM ro ll t':RxTING
C	 SUBROUTINE PROGRAM FOR WRITING
SU5ROUTINE .tiRI TE (R I N,M )
C
DOUBLE PRECISION R
DIMENSIOIN R(2,36)
C
C BEFORE INFECTION'lAE= TER INFECTION ANN AFTER CURE
C SAM P LE NO FROM 1 T n 12,
wRTTE (6,130)
DO 35 I = 1. M
35 11RI't^ (6 2 131) I,(Z(I,l.), L=1 + 36 9 3 )
k+RITE (611'10)
D L) G0 I	 1, M
40 WR TIE (6,1:1) I, (R(I,L), L=u,36,3 )
1rk71
- E (69150)
DO 50 I = 1,t'
WR ITE	 3	 z	 1	 36, 
.
3 F
G
	C SAMPLE NO FR0^1 1 TO 6 ,ILL VIRUS SAMPLE
	
a
1'4u ITE {6.1;60')
00 bC I = 11M
60 viRITE (6061) I, ( h(T,C.)r 1.=1,a )
WRITE (6 1 170)	 r
DO 70 I = 1,IM
70 WRITE (69161) I `11 ( R(7 9 L), L= 10,18 )
C
C SA M PLE NO FROM 7 TO 12, NOT ILL VIRUS SAMPLE
wuITE (61260)
DO 62 1 = 1 , `'
62 tV+RITE (6 9 161) I+ ( R(I,L), L=1392'1)
WRITE (61270)
DO 72 I
	 1,M
72 WRITE (6 9 161) I, ( R(I 1 L), L=28130)
C
1_0 FORMAT ( 	 INF IECTYON, 12 SAMPLES
/1	 M(^rA
	
If	 "	 "	 it	 . it	 It	 1 111	 +//,.	 K .SX, 1 • ! 1 6X 1 ?^, 1 6X, 3.., +
1	 6X	 bX,no"1na I)X4u7,,^1/^ hX'
r+g w 1 rl	 6X, lry,. 1", 5X, ,1 10.. 1l l a 5x,'`11-110,
131 FORMAT (I3 9 12FQ,2 ,// )
140 F 0R M4 T C ////18X,"**AFTER IN E.CTION, 12 SA10NLF3
1	
rt	 11	 v" 5v 1 It 4	 it	 "	 ^'^ 6 X '' 3	 is
1	 6Y, u^^2" 1 6X, Is	 fig o^ 7 u 6-2", 6X,"7 - 2", 6a9
1 1,1 8"2 11 9 6X. i'Y^a", 5X 1 "4G^`"^ 5'',''11- 2 111	 5^^1112-2
",Ji )
- 150 FORMAT ( ////,BA 11 -#k*FTER CUPE	 , 12) S MPLES1!	 ",//,
"PEAK" 5X 1 "1 «3",6x,	 ox, "3,,311 
1-	 6X,11p,^^"oXl r 5 » .7",
 
bX ll o .,j" + 6x,"7..3", oX`
^.	 "ASS", Ei:i ,act^, ,ll' z;X ,r n ^4r,^ tr t CJXrrr11„srr'
160 FORMAT (1N1,//iRX, n 	ILL , E, SA14 PL,ES -t *t***1k k ***^► * ** it *t * *^t ** t 1k * >Or ^ titk * **#;r*k** x^ 4k ** * i* * i >r ^ 1//^
30
16,422
	
UBROUTIN E PRO AM FOR. WRITING
1
	
	 6X."1-•3". 1 6X
6X 1 "2 „ 3",16X,"3 „ 1" 1 6X
6XIrr3- 111, //)
ib1 FOR-MAT ( 1a, 3F9 2.10X,3F9.2.l0X,_tiF'a.2.
_170 FORM AT-(	 ////, AX f r: *x* -,k ILL 1 Er
1	 "PEAK" .5x, "4 •• 1",6X, "4•• 2".6X, rl4 -3", 16X,	 s
1	 "S-1''.bX."5..^^", 6X,"S-•3''.16X,"6"1", 6X,
1	 a6 -2"	 6X,116- 311
2,50 F'UR.*44T(//i///,ax,"-*NOT ILL,6SOMPLES II
 //,"PEaKI',
•	 1	 r^X, 11.1„1 a 1 6X. "7-?".E+X, 117— J", 1 bX, IrS-, 1",6^,
1	 IrB.•2° I bX, nR -S",
 
16X, " y
-1 °,6X, "9'2" 1 6;<, "9n3i1,
270 FORM A T(////.SX,"**NOT ILL 6 5aMPLF_S **'I. //. "PEEK",
1	 4X, Ir l ^J — 1 n ,SX, ' I l ^r „ 2".S ,"1 0-3".15X,"1 1-'1",
I	 SX, t l 2 .SX, i l ^ 1 15X, 12 1 ,SX, 12 "2 ^
1	 SX,If12-3.11,// )
RETURP!
END
r
v
yi
J
•	 tltlt^'1
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16, 1-1 22 UBROUTINE PROGRA M FOR NORMA LIZATIO N
C SUBROUTINE PROGRAM F OR NORMALI7_ATIGN
SLIbROUT T
	
E	 NOi^' ,4 	 (A 9 N I M03	 )
DOUBLE	 PPEC I S i ON	 b , St)1••A
DIME'N510N	 4(37,36).E;(37,36),SUMA('36)
_C
C INITIALIZE DATA POINTS
00	 10	 J	 =	 1 1	 N
SUMA(J)X0.0
CONTI`1UE
WRITE
	 (61120)
DO	 40	 J	 =	 1,	 N
DO 50	 I	 =	 I,	 H
SU;^A(J)
	 =	 SUIM A (J)	 +	 A(I,J)
s0 f"OisTI INUr..
..•1
WRITE	 E6,121)
	
J,	 SUMA(J)
40 CON r1NU
r; RI TE 	(6,122)
DG.	 60	 I	 =	 i ,	 M
DO 70	 J	 =	 14
	
N
6(I,J)
	 _	 (	 A(I 1 J)	 *	 100	 )	 /	 SU ►:1A(J)
70 CONTINUE
WRITE	 (6023)	 (';,K),	 K^1 1 N	 )
60 CONTINUE
C a
120 FORtOAT	 (IHI,// /,"** 	TOTAL
	 PEAK	 AR EA 	 tq * *****	 *#><;*xtk
1,*^c* r******w *,t +t^kxra*^xtit
	 ^c*^t:t^;>r	 4n*>*".//^3x^
1	 "SAMP	 fg 0",5X,"T0TAL
	
.AREA",///
	 )
121 FORMA1	 (	 110,	 5X,	 f' 1 0 . 6 ,	 //	 )
122 °F0R,MAT	 (1N7,/ /,8X,"* *PERCENT	 NORM	 ALTZED	 DATA*******
' 1*yt4^s1r9t#+k'k^r9c%•ki•x•t#ic'k t***>^tx'f'*d;^'xxY;h•*-::*^ir^•^:x*x^,t^t1 y
"PE4K",2X,	 4Y•,"I	 p'+,4X 1 n I-33	 4X,
1	 4X,rl^', 'n2-3",u;,"3-1",Qyy
	
f'3-2'r
_	 1	 11	 11	 \^	 Ir	 n	 It	 11	 ..	 11	 11	 v
^' x ,	 3-3	 q4 x ,	 u" 1.V. uX j	 U, °^	 A^
1	 If	 1 )i t4 X 911 5- 11I' it X ,1iS* 	 t1	 X	 1'	 ra 1 rl	 4 v 	 Fl fa + 	 tl
1	 U x.1 11 6 y J7 i. t u ^ , / / y b X ^ 11 ^ r 1 11 y ^l X ^ 11 ^ ^, 11 ' ^t Y. t f1 ^ ,o •,,+ N ,
p A,^ n 5„I a o 4X^ Il e,-2	 ti;^if9'1'R„3nyp:C,°'^,.1"1t^A I1	
M9,.2"o4X,"'P
	 3 n 1 U X,"10-1" 9 3X 9 "10	 3X^
ri 10-3"9 3 Xi
sr 11 .. 1",3X 1 "a 1	 2",3X	 3,"12-11'13X1 ^1
123 FORMAT	 ( 7 3118F7.2 1	/,	 3X,	 18	 7.2s	 l / 	 3
RETURN
END
32
16.423 URROUTINE PROGRAM FOR MEANIS.D.,PERCENT COEF. VAR,
C SUc,ROU T I'V E	 PROGRAM	 FOP	 µEAN, S. U. ,PERCENT	 COE'_F . VAR.
SUEKOUTI N E	 CALL	 (	 ,La', , rdn:, KL,h',r^^F_'ntah,SDr;,PiCV )
DOLJ13L,E	 PRECISION'	 Sl^^?E:,Sr:i^,tF:ANS,ra TCv,SSnH,f3FTk ,f3
DIMENSION	 t3(3'1,Sh},^£a^^^(:^7),	 rF3(7,'/),F^TCvC3;),
1	 SUMH(,37),	 SSQS	 37)9SFTR(37)
C±
C	 .NITIALIZE	 DATA	 POINTS
DO	 10	 I	 =	 l,M
SUi^E^(I}=O.Q
10 rO,N T INUF
C H
r; ►RITE	 (6, 124)
OU	 80	 I	 =	 1 ,'^
DO	 90	 J	 =	 L,^.,KL
SU TA S(I')	 =	 SUMB(I)	 +	 BCI,J)
S806(1)
	 =	 Ssub(I)	 +	 B(I,J)	 **2
r	 90 CO-NITANUE
ME4.1,1 ; (I)
	 =	 SUMP C I)	 /	 NN
Br T R CI}
	 =	 SO R T	 (rJ Nx SS(jR (I) 	-	 3titi.;1(S)*x c )
SDf3CI)
	
=	 8FTR (I) 	 /	 ^:'N
FTCV(I)
	 (	 SD6(I)	 *	 l0Q	 )	 !	 NIF'4r4B`(I)
WRITE	 (6 9 125)	 I,	 M EaNB(I),	 iDn(I)t	 PTCV {76}
80 CONTINUE
124 FOPMAT	 (///,5W'**REPRODUCI :ILITY OF SELE(:TED FIEAKS
i	 **",//,^-iX, ► 'pEAK	 h(}",bX,"t-,Earv^^•lOX,"S.U^^^ d
1	 BX,nPT-C.V.",//) 9
125 FORMAT	 (	 10X , I5,_ 3F14.2,
RETURN
ENQ
i
I_
T
i
1
a
I
,r
16,4424 USPOUTINE
	 PRG	 ?Am	 FOR - VEAN 9 3.0.- .- iRCENT	 COEF.	 VAR,.
C S06ROUTINE	 PP	 A-M	 FO P 	 M EAtq ,S.D I-RCENT	 COEF.	 VAR,
-16ROUTINE	 Cl 	 C R I L I N , -MN vB'SDR,PTCV9
DOU6LE	 PkECIF	 SU0F3,SDiijME:ANB :V,SSwB,bFTR	 R
D I ME N.91 ON	 P	 MFAtM(2)jSD8( )TCV(2),5U,143(2)s
I	 SSQB	 3 F T R	 PC
C	 INITIALIZE DAT	 1 IN T S
DO
s um 8	 1	 0 . 0
ss f,, B 	 I	 =0 . ol
1 0 C'0 T 1 N U E
C
WR ITE
	
124
DO	 8,0	 1
Do	 96, 	L,NgKL
IF	 (	 IJ)	 GT .	 18.00 0	 Ti 0 .3G
IF	 (
	
,J)	 .GT.	 9.0 ; GO TO 30
SUMB	 SUMD(T)	 +	 RC
S 3 Q R	 ssni(I)	 +	 R( **2
GO TO
30 IN rq
90 C 0 N T I
MEANS	 SUMB	 NN
B F T P C I	 SORT	 (NN*3Sn6CI) w	 SU)Ab(jl)**2
SDBCI)	 SFTP(l)	 /	 NN
PTCV(l)	 9DB(l)
	
*-100 M 'E- A N k
WRITE
	
(6,125)	 1 1	 MEANBCI), S08(l),,PTCVCI'o
80 CONTINUE
124 F01-)t-l 1T	 C I H	 R F P P	 D Li C Al 8 T L I T Y	 0 •;	SLED.	 P L a K S
**IIl//t11X-j"PE4K	 hJcpl 1 6 x I rr C .A N 11L-	 9	 "S.D.
1	 8	 P r - c . v .
125 FORMAT
	(/j10Xj15,3Fll4.3q/
RETURN
Erin
tii
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16.423	 U;3KOUTINE PROGRA.44 FOR CALCULATION OF PEAK RATIO
C SUBROUTINE PROGR A M FOR CALCULATION OF PEAK RATIO
SUBROUTIINE
	
RATO(6,N,M9R)
DOU3LE PRECISION 8,R
01tMENS'10N	 8(7136),R(7136)
C
DO	 10	 K	 =	 1,M
DO	 20	 I	 =	 1, M
01 0	 30	 J	 -	 1 , N'
aR(T,J)	 YE(I,J)	 /	 B(K,J)
30 CO N T%NLIE
20 CONTINUE
C
C SAM PLE	 NO FR O4 	 1	 T O 	12,	 P E AK R ATIO-
C BEFORE	 INFECTION.AFTER	 INFECTION AND AFTER CURE
riRITE	 C6, 151)	 K
rt;lI T 	 (6, 13 0)
D n 35
	 I_
35 VJ R) I 	 (6,131)	 I,(R(141.),	 L= 1,36 1 3	 )
r;kITE	 (6 1 151)	 K
WRITE	 (6,140)
Y
40 ARITE
	
(6.131)
	
1,	 CR(1 9 L)4
	
L=2,36 9 3	 )
r:R1TE	 (6,151)
	 K
WRITE	 (5,150)
50	 I	 =	 1,IA
50',4RITE
D0
(6 9 131)	 Iw	 C	 P(1 9 L),	 L.=3,	 36,	 3	 }
CC SAMPLE NO FRO . 	1	 TO 6	 ,PEAK RA7I0
C NOT ILL	 VIRUS	 S M1f; LES	 1
WRITE
	 (6,151)
	
K
WRITE	 (6060)
DO	 610
	
r	 =	 1 114
60 WR ITE	 (6,16 1) 	 I 9 	C	 R(I,L),	 L=1,9	 )
V;RLT^	 C4, 17U)	 •
00	 70	 I	 =	 11^a
70 WRITE	 (66161)	 I,	 (	 R(I,L),	 L-10 1 18	 )
C
C SAMPLE N.7
	
FRO-M	 7	 TO	 124PEAK RATIO
C ILL V1 RU S	 5AMPLE3
WR 11E	 (6y1 51)
	
u
WR ITE	 (6, 260)
00	 62	 I	 =	 19titi
62 WRITE	 (69 161)	 I,	 (	 R(I,L)•
	
L=19,27)	 ,I
%VRITE	 C69270)
DO 72	 T	 =	 s IM
72 'WRITE	 (6.16%)	 1,	 (	 R(I,L) •
	
L=29,36)
10 CONTINUE
C
30 FGRMAT	 t	 //;/,8X,"**8EFORE	 I N FECTION t 	12 SAMPLES
*	 r+ 9 //,^Sr ` p k rt ,5X, u 1^1'",6X	 "2-1",6X,"3-1",s
I,	 6X,Ilill-1'',6X,	 1n,	 6X ,"L• -1",	 6Y,"7-1",	 6X,	 ^.
aY^ ^^
h$„1"^	 ,6X^MC;..1^^^	 ^X^n10,.1n^	 SX^i^1i^1^ •	 .
16.423	 U5ROUTINE PROGR.
1 5X,1112-1"°//	 )
131 FO R MAT (I3 9 	12F9.2	 ,//
	 )
140 FO RMAT (	 ////,8X, ",..*AFTcR:	 INFECTION,
	 12	 SAt"PLES
1 ^i•w	 //I n^CA K 11 15 ,{	 n1X2,1	 6X°u2-21s°SX,u3-fits
1 6X 1 11 4-21 1 4 bx ° 115..211	 C, X, "6-2",	 6X,"7-2",	 6X I s
1 1,1 8- 1 2",	 6X," 14-?",	 5X I 11 10-2 f1 ,	 5x,'"i1-20,
1 SX, Il 12x2" ° //	 ) ^
150 FORMAT (	 /// / 1 89, 11 **LFTER
	
CUBE
, 	
	 12	 SAMPLES
1 '^. Yt "	 / /	 11 P L {i `/ 11	 i v	 11 1 —	 tl , U y ° ()	 -	 ^i	 b ^	 tl	 Z 111..	 V J H °	 i	 I	 ,	 J
1	 _ GX,11a^^1' 16X I " 5°J" I	 CX, " b - 5 11 ,	 6X,"7^3'' °	 6X,
1 " 8 -2 11 I	 6X, Ity - ; 11 ,	 5X, 111 0 - 3 " °	 5X., 111 1-7J
i 5X,7"12-3",//	 )
151 FOR,'AAT (1Hi,//,2x,"K=",T2,3X,"^r* 	 PEAK	 RATIO	 t	 ***	 * s
160 FOr' Ni. T rio't	 ILL	 ,	 6	 SAM;:'[ J.5
	
x *	 ,//,
1 11PEAKIf Ir,X,"1.. 111,6X,"l-^2",bX',",..3'1, 16X
1 ';2 - 1 " , 6 X. " 2 - 2 " q  	 "	 ti	 l	 11	 ^t	 11cX,	 2	 ^',ihX,	 1	 I	 bX, y
1 11 3-?. 1' ,	 6X, 113-'3"
161 IF ORMAT (	 13,	 3 P R.2, 10x I y F1.2, 10X,3:9.2
174 FORMAT Ll.	 1•	 6	 S^r•^^i'ES	 **t1^//9(„//// /,C1X0,1^I- *11'^nT	
I?.1 ^ E 1iK	 15X,	 .6X,	 u -1	 ",6X, tl(j_3"..1.6x ,
L	 /	 6If	 11'6XI tsS—]$I,
	 Vn°11C-21^C1^XS " b-1 't I	 VY,a
1 " 6 -3",// "6	 2" ,	 6x' )
260 FORMAT (	 ////,8X,"**	 ILL,	 6	 SAMF5LF_8* *111 //,f'PF,1K",
1 SX I,r7-11116X 1 "7„21, 1 6x, "7-3", lbx	 ,6X,
1 11ao	 111118-311 	 1 11	 n	 "	 1"	 "	 111	 -^,i2	 ,bX 1 16X	 y	 1	 ,bX	 9-2	 1 b)(9	 s )
i
2701EDRF'A? 6(//////03X,"**	 ILL.,	 SAMPLES**",//a"PEAK",
4X,"10-1"15X11110-2",SVI"10—j",15x,"11-1t11
1 5X1" 11-2",5x, 11 11.-3 ,, , 1`;X,"12-1"15x'I"12-CIt I .^
' 5X1111 2-'3",//	 )
RETURN
END
yq
t;
n
x
d
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16.42 u
	
UBPROGRAM FOR AUTOSCALI iG
I
C	 SUBPROGRAM FOR AUTO,SCALING
SURROUTI NIE 'OUTS (1AjN,`r ,MEA?4B.SD8,ASLE3 )
DOU,iLF PRECISION	 r3
DI MENSION 6(2,36),ASLB(2136),MEAtJ8(2),SDB(2)
C
WRITE (64 120)
DO 93 I = 1 + M
DO 95 J = 1. N
ASLB(I,J)=(r3(I,J)- M EANB(I)) / SDB(I)
95	 CONTINUE
.'tRTTE (b, 121 ) I, (ASL6(I,K) yK=1, N)
93	 CONTINUE
C
120 FORMAT (1H1,/ /,8X,"^*AUT0SCA LED PEAK RATIO?*******
1 ' kttit74*>; is^cftrc'!'st^: >ti^'^'^^#:cx+kiris*kk^r*fit* 7M xt^^cX^yrit*ix>k:k h , //^
1	 tt2K HT^.)" 1 11 1 .. 1 " . 14 X, "I r2",0X, t1 1	 X,
1	 n2„ 191.4 X," 2„2 11 ,uX,"d-3If 4X, 11 3-1 tt
 4X.`'3—?;'
1	 u^'tl 3—a11^^jX^ItLl-ito
	
X^r.u,21t,UX,114—jit
1	 11f)^yt	 115-P11	 14X	 fir-- 	 •(^x.^ll^-1 fi t ^lX ' :1 ^,^^tl^
•1 	 uX,`' 6^3", UX,//, bX, u•1-1
 .4X," 7 „ 2 n 4' 11 7-3 11 .
1	 rs X^n 8^111.!: X,rIS-Prt^l+^'t1^..7,:1,(#X, "9^1 ",ux,
1	 y^,.2t,^4X^11q.3t1uX,111^^1",3X,",109?",3X,
1	 '' ' 11-1"13X, III 1 - 2 11 1 3X, 1t 11-3 11 3Xv"12-1 11 3X,
1	 1112-2"13X."12-3", /// )
121 F'OR^I AT (T3, 16F7.2,/,3X 1
 18V7.21
RETURN	 -- -
END	 y
1
i
i
C
C,
SUBROUTINE F'i
AND CLASSIFICAT:
UfIROUT I NE S(
DOU[st.E PREC I S.1 1 1 4 u
DI MENSION JJ(10), -0( 26,10)
C
C s
WRITE	 (69220)
DO	 50	 K_ =	 1,M
Ll	 =	 L	 -	 1
DU	 a0	 T	 =	 1 9 	 L. 1
IPI_=	 I+_1
DO	 30	 J	 u	 !P1,	 L
IF	 (	 D( K ,T)	 .L.E. D (K	 J) ) GO TO .3 0 Y
TEP.P=D (K , I )
D(Kjl)7-1)IK, J)
D(K,J)=TE,4P
T Em P = J J (I )
JJ(I)=JJ(J)
JJ(J) =TEM Pl
30 COQ` 7	 UE
40 CONT1NUE
Vi TTE	 (6,221)
	
K
45 'VJ RI f E	 (6 9 222)	 j J(J) i	 D(K4J)
DO	 46	 Kid	 =115,2
WRITE	 (6 4 223)
	
KN
IF	 E	 KN	 .Ek^.
	
1	 ) LL=! -3
IF	 (	 KN	 ,ECG.
	
s	 ) LL,
IF	 (	 KN	 .EC,	 5	 ) LL=S
KNA=O,
KNB=O,
DO	 47 J »	 I , LL
IF	 (JJ(J)
	 .LE.	 5 )	 GO TO 10
IF	 (.IJ(J)
	 .GE.
	
6 )	 GO TC, 20
10 KrdB=KN8	 +	 1
GO TO 47 f
20 KNA=KNA	 1
47 CONTINUEI 	 (	 KiN i	 .GT.	 K N A )	 GU TO 11
IF	 {	 KNEE	 .LT.
	
K N A )	 GO TO 12
11 ` v,*RITE	 ( 0 4224)
GO TO 46
12 v+RITE
	
(6,225) 1
46 CONTINUE
DG	 48	 I	 =	 1,^
48 4T J(1)	 =	 I
s
SO C0NTINUE
i
38
2 0 F(;P?-6 T C 1 r+1 , // "*+ K
—?^'N CLASSTF 1Ca T ION, SO P TING +* trr
2r 1 F(lk ? - i AT -AllP	 13
222 FOK M AT	 (10a, 10(VI,	 F^l	 ?,
224 -FO= Na T(5x," CLA5•51FiE• U	 ;:S	 f`EFOkE
	 T. NF _CTI)N^",//)
225 F CJP( ' A T(SX,° CL A SSIFIED	 AS	 *:t i AFTEf-	 1NFECTIO^b^"j//)
RETURN
END
7
t
i
Y
J
a
v
r
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II I .	 RESULTS AND DISCUSSION
A. Transevaporator Sampling System
The modifications of the transevaporator technique described here,
result in better overall reproducibility and eliminates the problem
of the precolumn blocking during desorption due to the presence of excess
water vapor.
The major modification is that a "headspace" trapping is performed
before the solvent extraction step. Minor modifications are the
substitution of glass beads for glass wool, the removal of the Porasil
E tube and the warming of the helium during the evaporation of excess
2-chloropropane when the transevaporator is used in the extraction mode.
Glass beads have been found to be a more efficient trapping material
than glass wool. No differences have been found between silanized and
non-silanized beads. Heating the helium carrier reduces the evaporation
time for 2-chloropropane from about 20 minutes to 7 minutes. n-Pentane
was substituted for 2-chloropropane in a few runs.. This resulted in a
lower extraction of volatiles without significantly changing the shape
of the profiles.
Due to the small volumes involved, the transevaporator technique
is faster than a macro headspace sampling using a Tenax trap or a micro
extraction technique. Thus a Complete transevaporator run with
collection on both a Tenax and a glass bead tube takes about 30 minutes
which is about the same time as required for a normal headspace sampling
of a large sample on Tenax.
,ice
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Figure 4 shows a typical chromatogram of a ten standard component
mixture on 5% I.-Jitconol LA-23 stainless steel capillary column gas
chromatographic system (2.6 ppb each component in distilled water).
This mixture was used for testing the efficiency of the transevaporator
sampling procedure.
For the technique of profile analysis to be useful, it is essential
that replicate runs of the same sample yield near identical chromatograms.
The reproducibility of the entire transevaporator/desorption/chromatography/
integration technique was investigated by perform i ng replicate runs of a
100 pl aqueous sample consisting of 1.3 ppb of each of the following
components: n-propanol, n-butanol, 2-heptanone, benzaldehyde and 2-
decanone. The transevaporator was operated in the 2-chloropropane
extraction/glass bead collection tube mode. Table I lists the standard
deviation and relative standard deviation for both retention time and
peak area. The standard deviation for retention time varies between 5.
and 10 seconds and appears to be independent of retention time. Thus
retention time is an adequate parameter for defining the identity (in
the context of profile analysis) of all but the earliest peaks.
In the case of peak areas, it is more meaningful to compare relative
standard deviations, which, for the compounds considered, vary between
4.5% and 9.8% in a random manner. These values are acceptable for
compounds in the sub ppm^range and may be considered surprisingly good,
if the degree of sample manipulation is considered. Our prime interest
is in the profile analysis of biological fluids where components in
"Normal" samples are likely to vary over a range of 20% to 50%. Thus
•
FIGURE 4. CHROMATOGRAM OF A TEN STANDARD COMPONENT MIXTURE
ON 5% WITCONOL STAINLESS STEEL CAPILLARY COLUMN
(100 m x 0.25 mm, I.D.)
1. Acetone	 6. Cyclohexanone
2. Ethanol	 7. 2-Methyl-2-
heptene-6-one
3. n-Propanol	 8. Benzald,ehyde
4. n-Butanol	 9. 2-Oecanone
5. 2-Heptanone	 10. 2-Undecanone
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TABLE I. STANDARD DEVIATIONS OF RETENTION TIME AND PEAK AREA
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Retention. Time Peak Area
Sample Mean Value . Standard Relative Standard Mean Value Standard Relative Standard
(min) Deviation Deviation M (counts) Deviation Deviation M
n-Propanol 26.54 0.11 0.41 9401 916 9.7
n-Butanol 36.46 0.16 0.44 37320 3228 8.7
2-Neptanone 41.81 0.08 0.19 65868 5559 8.4
Benzaldehyde 61.56 0.10 0.16 83330 3741 4.5
2-Decanone 67.40 0.08 0.12 63810 6255 9.8
43
changes in concentration of less than 100' are not considered significant
and a relative standard deviation of low is more than adequate for the
combined sampling and chromatographic technique. No increase in
precision is obtained by considering either relative retention time or
relative peak area. The reproducibility of the the technique is further
illustrated in Figure 5 which shows three replicate runs of 60 ul of the
same normal serum using the transevaporator in'the 2-chloropropane/glass
bead mode. The reproducibility is excellent, and with the exception of
a few areas, the chromatograms are visually identical. The reproducibility
is similar when the transevaporator is operated in the Tenax mode.
The linearity of overall response is good when the transevaporator
is operated in the 2-chloropropane/glass bead mode as is shown in
Figure 6 for a variety of aldehydes, alcohols and ketones. However the
actual recovery (comparing aqueous sample introduced into Porasil E
tube to equivalent amount of.dry sample directly introduced to glass
bead tube) varies from about 20% to 80% for the five compounds illustrated
in Figure 7. The recovery varies slightly over a concentration range of
0.3 ppb to 5 ppb but is remarkably consistent, considering that the
actual weight of each component is in the nanogram range. Because of
this consistency, the non- identical recovery for different compounds is
of little consequence to profile analysis which is a comparative rather
than an absolute technique.
The chromatogram obtained from a given sample when using the
transevaporator sampling technique depends on a number of factors such
as the nature and volume of the solventused for extraction, the volume
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FIGURE 6.	 PLOT OF PEAK AREA VS CONCENTRATION OF
VARIOUS COMPOUNDS DISSOLVED IN 100 ul
OF AQUEOUS SAMPLE
1. n-Propanol 5.	 2-Decanone
2. n-Butanol 6.	 2-Heptanone
3. Cyclohexanone 7.	 2-Methyl.-2-hgptene-
6-one
4. 2-Undecanone 8.	 Benzaldehyde
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FIGURE 7. PLOT SHOWING PERCENTAGE RECOVERY VS CONCENTRATION
FOR FIVE COMPOUNDS DISSOLVED IN 100 ul OF
AQUEOUS SAMPLE
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of adsorbents and the temperature and volume of gases flowing through
the apparatus during the trapping procedure. Thus,a standard set of
conditions must be chosen for the complete procedure when comparing
profiles. A blank should be run periodically to check for contamination
of the system.
The transevaporator technique has been applied to a large number of
diverse samples in our laboratory. It is especially attractive for
biological samples due to the small sample size requirements.
Chromatograms of normal serum volatiles (Figure 5) collected using
the transevaporator in the glass bead mode were referred to earlier in
connection with reproducibility studies. Figure 3 shows the corresponding
chromatogram for a serum sample collected from a diabetic patient.
About 200 peaks are present in each of the chromatograms. The heavy ends
of the chromatograms are visually different. In addition there are
several quantitative differences between the two profiles that are
evident from inspection of an integrator print out. Figure 9 shows the
chromatograms obtained from a diabetic serum using the transevaporator
in the Tenax mode. In these profiles the relative size of the
arrowed peaks is reversed in normal and diabetic serum. It is
interesting that Figure 9 shows a very similar chromatogram to that of
Liebich et al. (38 ) The latter workers used 5 ml of serum.
Differences are also found between the profiles (Figure 14) of the
sera of influenza patients and the sera of controls. These differences
are manifested by a greater overall concentration of volatiles in the
infected sera and by*ratios of peak areas that are characteristic of
either the infected or non-infected sera.
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The transevaporator technique is well suited to other body fluids
apart from serum.	 Figure 10 shows the profile of 2
.
00 pl of saliva using
the transevaporator in the 2-chloropropane extraction mode.
	 The late
peaks are small but their size could be increased four fold by increasing
sensitivity without introducing noticeable noise.	 This profile, while
not having as many volatiles as a serum profile, is of interest to
biomedical	 studies due to the ease of obtaining samples. 	 A profile
(Figure 11) was also determined for 50 pl of breast milk which, due to
its viscosity, was first diluted with an equal volume of distilled
water.	 The profile is complex and the concentration of volatiles is
larger than in serum. 	 It is estimated that an adequate profile may be
obtained with as little as 5 pl of breast milk.	 Theprofile has
virtually no resemblance to commercial cow milk which has a relatively
simple profile.	 The transevaporator technique is not suitable for urine
due to the low concentration of volatiles.
Figures 12A and 12B show the different profiles obtained from
samples of cognac using the transevaporator in the Tenax mode and also
in the 2-chloropane/glass bead mode.	 Other samples that have been run by
this technique include wine, cola, pressed coffee oil and brewed coffee
(Figure 13), all	 of which give complex profiles. 	 Differences'between
Robusta and Arabica coffee were found for the latter two sample types.
B.	 Volatile Compounds in Virus Infected Serum
A typical chromatogram obtained from a pooled virus infected serum
sample is shown in Figure 14.	 Peaks identified in the chromatogram by
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GC-MS are summarized in Table II. 	 The peak numbers in Table II correspond
to those marked in Figure 14.
 `We have scanned a,bout eighty peaks in the
chromatogram, but only about twenty four peaks could be identified.
	 In
the chromatogram (Figure 14) peak number 17 appears as a well defined
single peak, but its mass spectrum, in Figure 15, indicates combination
of two peaks;
	 cyclohexanone and 5-methyl-3-heptanone.
	 Five of these
substances (peaks 5, 8, 10, 13, 28) have been identified previously in
normal serum.(38)
C.	 Profile Analysis of Virus Infected Serum
A total of thirty=six virus infected and normal serum samples as
well as six pooled serum samples were studied.
	 The processing of a 70 111
serum sample including sampling by the transevaporator technique,
separation by gas chromatography and data input and computation can be
completed within a 2.5 hr period.
The profile of volatile substances in serum is complex with more
than 150 peaks in the chromatogram. 	 To simplify data handling, a visual
comparison was made of all chromatograms, peaks due to background and
stripping solvent were ignored and 37 peaks, which appeared consistently
in all chromatograms were selected as the data base.
It was known that the coefficient of variation for the excretion of
the major and consistently excreted metabolites was large.	 Dietary
alteration produced relatively small changes in patterns but large
individual within-subject variations were observed. (30,18,69)	 Six
replicate analyses of a pooled serum sample was used to establish the
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TABLE I3.	 SUBSTANCES IDENTIFIED BY GAS CHROMATOGRAPHY/MASS
I
I
SPECTROMETRY IN VIRUS INFECTED SERUM. COMPONENTS
INDICATED BY NUMBERS IN FIGURE 14.
Peak Molecular-
No. Compound m/e Weight
1 2-meth 1-1-hexene 57 41 29 40 45 58 56 27 98
2 dimethylcyclopentane ' 56,41,55,70,42,69,39,57 98
5 2-propanol 45,43,59,31,27,29,44,46 60
7 2-hexanone 43,58,51,41,29,100,85,71 100
f.,	
8 n-hexanal 44,•41,43,29,45,55,72,82 100
10 n-butanol 56,31,43,41,26,27,42,57 74
12 2-heptanone 43,53,71,59,41,114,99,85 114
13 heptanal 44,70,43,55,57,42,29,41 114
14 4-heptanone 71,43,41,27,39,42,114,29 114
';
15 4-octanone' 43,71,57,58,85,41,86,128
x
128
16 6-methyl-2-heptanone 43,58,71,95,85,110,70,59 98
17 cyclohexanone and 55,43,98,27,42,69,70,41 98
5-methyl-3-heptanone 43,57,71,72,99,29,128,41 128
19	 - 2-octanone 43,58,59,71,85,128,123,109 128
20 n-octanal 43,44,41,56,57,34,29,5;5 128
22 6-methyl-5-heptene- 43,44,108,55,69,58,67,111 126
2-one
23 5-nonanone 51,85,58,41,142,43,42,100 142
25 2-ethylhexanal 57,72,41,43,29,50,71,55 128
x
58
TABLE II.
	 (continued)
MolecularPeak
No. Compound m/e Weight
27 2-octenol 57,56,44,43,41,29,70,82 128
23 benzaldehyde 106,105,77,41,42,40,78,43 106
29 2-ethyl-1-hexanol 57,55,41,43,46,70,83,69 130
30 2-decanone 58,43,59,71,29,57,41,55 156
32 D-tolualdehyde 120,119,91,65,82,121,51,59 120
33 acetophenone 105,77,120,51,43,78,106,50 120
34 trimethyl-2- 96,138,81,109,67,95,97,123 138
cyclohexanone
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magnitude of system variation within the data base (i.e. the effect of
experimental variables on reproducibility)., All peaks were normalized
and the percentage relative standard deviation calculated. Reproduci-
bility depended very much on the compound Itself and consequently a
wide variation was found between individual peaks reflecting their
different chemical properties. The smallest variation was 6.5% (peak 20),
a median value 18.3% (peak 5) and the largest 51.1% (peak 21) relative
standard deviation.
Another source of variance is the variability between individuals
in any one group.	 was calculated for eacharoup in turn for the
37 peaks. All peaks were normalized and their variance calculated. For
example, the 12 serum samples of Group I (normal serum) had a•lowest
value of 17.1% (peak 1), a median value 32.9% (peak'32) and a highest
value of 87.5% (peak 4) relative standard deviation. Results for
Group (III) were similar but Group (II) showed far less variation.
A second data set was selected based on the magnitude of the
difference between the averaged normalized peak areas for the different
groups. The criteria for selection was that the relative standard
deviation of the selected peaks must be greater than the variation
between individuals in any one group. Seven peaks were found to meet
this requirement (peaks 16, 19, 20, 25, 29, 31, 34).
The normalized peak areas in the second data set can show both
negative and positive variation between groups. Under these conditions
a ratio of two peaks should prove more sensitive to inter-group differences.
Also,' if there is an interaction between peaks in each group then peak
e.
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ratios will be more reliable for classification purposes. The seven
normalized peak areas were arranged in ascending order and all possible
peak ratios calculated for Groups I and II. The two peak ratios 16/25
and 29/34 were found to be most suitable for sample identification.
The reproducibility of retention time and normalized peak areas
for the four selected diagnostic peaks in the pooled serum sample (six
replicate analysis) is shown in Table III. Retention times can be
reproduced very accurately in the analytical system and this forms an
adequate parameter for peak identification. The relative standard
deviation of the normalized peak areas between individuals for the four
selected peaks is`given in Table IV fo.r Groups I through III. The
	 y
variation in peak area for infected serum (Group II) is much less than
normal serum (Group I) and can be more correctly defined. Peak 25 in
Group I shows a greater variation than the others due to the inclusion
of one e-=-traordinary large peak in the data set.
1. Differentiation Between Normal Serum and Virus Infected Serum
	 ^a
To differentiate between normal serum (Group I) and infected serum
(Group II) the two peak ratios 16/25 and 29/34 are calculated in Table
_	 r
V. Visual inspection shows that generally the peak ratio 16/25 usually
dec.-eased upon virus infection (except samples 7, 8, 9) and that the
pp^k ratio 29/34 increased by virus infection (except samples 2, 3, 5).
However, the use of either peak ratio does not in itself provide a
sufficient classification between the two groups. The autoscaled data
set of Groups I through III is plotted in two peak ratio dimensions in
62
TABLE III. REPRODUCIBILITY OF NORMALIZED PEAK AREA AND RETENTION TIME
a	 E
WITHIN A POOLED SERUM SAMPLE (6 REPLICATIONS)
% Normalized Peak Area Retention time (min)
Peak
Number mean S.D. % C.V. mean S.D. % C.V.
16 5.36 1.44 26.9 53.75 0,57 1.0
Y
r,
25 1.34 0.25 18.8 65.82 0.63 0.9
29 4.15 1.37 31.7 76.51 0.62 0.8
34 1.42 0.29 21.0 89.77 0.80 0.9
i
*percent relative standard deviation
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TABLE IV. VARIATION OF NORMALIZED PEAK AREAS FOR THE SELECTED
FOUR PEAKS IN ALL SERUM SAMPLES
1
Relative Standard Deviation
One Day After 4-21 Days After
Peak Before Infection Infection Infection
Number (Group I) (Group II) (Group III)
r
16 48.9 32.6 44.2
25 89.9: 20.4 47.4
N
29 36.3 32.7 30.5
34 53.8 30.3 62.9
4	 e
^..	
- _
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TABLE V. SELECTED TWO PEAK RATIO DATA AT DIFFERENT VIRUS INFECTED CONDITIONS
Peak Ratio (16/25) Peak Ratio (29/34)
Sample	 Before One Day After -21 Days After Before One Day After 4-21 Days After
Number	 Infection Infection Infection Infection Infection Infection
Serum Samples with Clinical Symptoms After Exposure
1	 17.73 4.16 8.73 3.53 7.30 5.54
2	 T7.93 8.90 9.65 3.85 2.56 3.11
3	 24.28 4.77 3.71 44.00" 3.24 6.17
4	 3.32 2.80 3.67 3.57 4.65 1.88
5	 15.78 2. 611 5.77 4.15 3.70	 ,, 3.55
u	 17.48 9.51 12.07 0.69 . 2.43 1.82
Serum Samples with no Clinical Symptoms After Exposure
7	 3.38 9.03 8.97 0.99 4.13
i
1.-35
8	 6.58 5.05 31.51 0.66 4.40 5.21
9	 1.35 1.44 7.56 6.13 7.23 23.22
10	 9.24 4.95 2.75 1.94 11.89, 1.75
11	 33.69 5.59 4.59 1.54 2.52 4.00
12	 17.59 8.24 23.15 1.99 8.43 2.22
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Figure 16. It can be seen that two separate clusters are formed for
Groups I and II and thus the two peak ratios selected are adequate
for the identification of normal and infected serum.
In order to test the predictability of the proposed method the K-
nearest neighbor approa6i was used. A randomly chosen training set of
ten serum samples (5 normal and 5 infected) was used to assess the
predictive accuracy of the two peak ratio technique using the remaining
14 samples as unknowns. Figure 17 shows a computer print our of
Euclidean distance in two factor space (16/25 peak ratio and 29/34 peak
ratio). Five normal sera training set is designated as 1 -* 5 (B1 -)- B12)
and the other five infected sera training set as 6 -* 10 (A 1 - A.). In
a given sample, the Euclidean distance between sample point and ten
known points of the training set were rearranged by'a sorting process.
Figure 18 is a final print out for K-NN classification "before
'I
infection (normal)" and "after infection". This can be done simply by
	 I
reading the first columns in Figure 18, according to already fixed K
values (k = 1, 3, 5 ...etc.).
Predictive ability was calculated as the percentage of the 14
unknowns correctly classified. The three nearest neighbor (3-NN)
computation assigned 85.7% of the samples correctly (I-NN, 71.4%; 5-NN,
78.5%). Clearly the proposed method has excellent selectivity for the
differentiation of normal and virus infected serum.
After 14-21 days (Group III) complete recovery from infection is
observed clinically. However, the two peak ratio classification places
appr
o
ximately half the serum samples in the virus infected category.
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FIGURE 16. AUTOSCALED TWO PEAK RATIO DIAGRAM.
I. Normal Serum before infection;
II. Infected sera (24 hr)
o, Recovered sera (14-21 days after
infection).
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DIFFERENTIATE BEFORE AND AFTER INFECTION GROUPS.
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The implications of this finding can only be speculated on at the moment,
especially as normal samples are correctly classified by this technique.
2.	 Differentiation Between Normal Serum with Clinical Symptoms
After Exposure and Normal Serum with no Clinical Symptoms
After Exposure
The general usefulness of this profiling technique would be enhanced
if it could be used to predict susceptibility to virus infection.
	 :The
r
normalized two peak ratio data for Group I (normal serum) samples is f+"
shown in Figure 19.	 Samples Il through 16 were normal serum samples
from volunteers who upon exposure to virus infection developed clinical
symptoms of the disease and samples I7 through I12 did not develop
clinical	 symptoms upon infection. 	 Again two well defined clusters (with 1
two exceptions I6, I9) are formed and demonstrate the possible use of
the method for the diagnosis of virus susceptibility.
	 However, the
a
twelve samples available are too small a data base to provide a training
set and sufficient unknowns to test the predictability-of the method. 	 A
much larger sampling program will be required to assess the accuracy of
this method for the determination of susceptibility to virus infection.
i
E
1
n
p70
.	 I
FIGURE 19. TWO PEAK RATIO DIAGRAM. SAMPLE 11 THROUGH
16 ARE NORMAL SAMPLES FROM VOLUNTEERS WHO
CONTRACTED VIRUS INFECTION AFTER EXPOSURE.
17 THROUGH I12, AS ABOVE EXCEPT NO CLINICAL
SYMPTOMS DEVELOPED AFTER EXPOSURE..
o, Recovered sera (14-21 days after infection).
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IV. CONCLUSIONS
Complex profiles may be obtained from aqueous samples in the volume
range from about 5 pl (for very concentrated samples) to about 200 Ill
u
by the transevaporator technique for a wide variety of biological and
other sample types.	 Both a "headspace" and an extraction profile may be
obtained from the same sample.
	 These methods are complementary as
each emphasizes different parts of the profile.
	 The precision of the
Y
method is good considering the small sample and the trace quantities of
vol ati l es- present.
The transevaporator sampling technique is shown to be useful for
the volatile profile analysis of 70 ill of influenza virus infected sera.
A two peak ratio method has been developed for the characterization of
normal and virus infected sera with a percentage predictability of 85.7%
of correctly classified unknowns.	 A similar two peak ratio method is
indicative as a possible means for the assessment of virus susceptibility.
The technique may be used to show differences between normal and
diabetic sera,, and between Arabica and,Robusta coffee for both pressed
coffee oil and brewed coffee.
i
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